about
The influence of micronutrients in cell culture: a reflection on viability and genomic stabilityMaternal intake of supplemental iron and risk of autism spectrum disorder.Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.Iron in relation to gastric cancer in the Alpha-tocopherol, Beta-carotene Cancer Prevention StudyDNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemiaTelomere length and elevated iron: the influence of phenotype and HFE genotypeHigh ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease.Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.Relationship between Hepatitis C Virus Infection and Iron Overload.Iron metabolism: from health to disease.Iron: the hard player in diabetes pathophysiology.Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases.Pure erythroid leukemia.Infant birth outcomes are associated with DNA damage biomarkers as measured by the cytokinesis block micronucleus cytome assay: the DADHI study.Leukocyte telomere length is inversely associated with post-load but not with fasting plasma glucose levels.Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer.Haemochromatosis and gastrointestinal cancer.The role of anaemia in oxidative and genotoxic damage in transfused β-thalassaemic patients.Should every Patient with MDS get Iron Chelation – Probably Yes.A strategy for the clinical remission of acute lymphoblastic leukemia elicited by treatment of β-thalassemia major: A case report.Should every Patient with MDS get Iron Chelation - Probably Yes.The effect of iron-vitamin C co-supplementation on biomarkers of oxidative stress in iron-deficient female youth.Nano-Mechanical Response of Red Blood Cells
P2860
Q21284821-724B66A0-3525-4F62-83C4-50EE834984B1Q34395256-ED98A562-988C-4552-852C-49406337922FQ36144711-B7CC5971-C837-4BE9-82DD-617D97A1717EQ36385223-3789A2D4-4F67-4CCA-AD2A-0A5A8E622456Q37055329-A6F2E893-3342-4657-97C9-85A19187BAB6Q37201107-B54509D3-07DC-403F-ACE2-BCC39A9C34C7Q37369954-97C9DE64-EA3D-4393-8A6A-A11B4E39CD69Q37458594-B8CF6328-8CA5-4ACD-989F-93D50FAB869CQ37738317-C4588536-AB1D-4CD7-A9B4-3C7313D982D5Q38183337-C30DD9EC-0268-4255-A174-2CFD9232FEBDQ38187484-C9860CE3-8358-4F83-BC06-3A41C1E61FECQ38203153-54735033-7641-4513-9895-26C2EF60A42CQ38779206-0531D032-1340-4322-879C-8817091F364BQ38878646-952D931D-AE92-4457-B3D2-919992AE60CFQ38904043-1762C151-E12A-4F7D-A0FA-E47A466B2D8FQ40343605-E9A10800-92BA-4277-98B5-AD116DC0CA7AQ40701829-6A7FC9B9-6C32-4A3F-BE5C-D9F362778A62Q46466632-1DFFFEA6-E201-4FF1-8F2C-65206030A9EBQ47140948-C4FE9712-68F5-4062-A32F-06D04A4FDF0DQ49414066-8FFDAD26-8F6F-48FF-A714-C82BB2DC18A7Q50144442-1EBBE8AD-8404-43E6-AD85-CB9647728CE3Q51242287-89924AE5-D626-4633-AEF8-F7C4088C4DE4Q58452858-90C0AC5D-4131-4064-9151-22B6AD67AFB5
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Iron and genome stability: an update.
@ast
Iron and genome stability: an update.
@en
Iron and genome stability: an update.
@nl
type
label
Iron and genome stability: an update.
@ast
Iron and genome stability: an update.
@en
Iron and genome stability: an update.
@nl
prefLabel
Iron and genome stability: an update.
@ast
Iron and genome stability: an update.
@en
Iron and genome stability: an update.
@nl
P2093
P1433
P1476
Iron and genome stability: an update.
@en
P2093
Daniel Prá
João Antonio Pêgas Henriques
Michael Fenech
Silvia Isabel Rech Franke
P356
10.1016/J.MRFMMM.2012.02.001
P407
P577
2012-02-13T00:00:00Z